Investment Thesis

Kenvue Inc. is a BUY at current prices due to its strong positioning within the consumer health sector and the market's mispricing of its potential growth. Despite being newly established, Kenvue's comprehensive product offerings across self-care, skin health, and essential health segments present significant revenue-generating opportunities that are not yet fully recognized by investors.

Competitive Moat

rooted in intangible assets, primarily its strong brand equity derived from legacy Johnson & Johnson products. This brand loyalty, combined with established distribution channels, creates substantial switching costs for consumers. Over the next 5-10 years, Kenvue's moat is expected to remain durable, although it faces competitive threats from private label products and emerging health brands that may erode market share.

Growth Engine

Kenvue's future revenue growth will stem from expanding its total addressable market (TAM) through innovative product lines and geographic penetration. The consumer health market is projected to grow significantly, driven by increasing consumer awareness of health and wellness. Kenvue is well-positioned to leverage its existing brands to introduce new products and enter emerging markets, capturing additional market share. The company is currently gaining traction within its core segments, bolstered by a strategic focus on organic growth.